Latest Commercialization News

Li-S Energy’s lithium-sulfur battery powered the Pegasus drone through an almost two-hour Queensland flight covering more than 75 kilometres. The result strengthens the technology’s aviation credentials, but the partners are still assessing commercialisation rather than announcing sales.

Gratifii narrowed its FY26 net loss to $7.56 million, but continued cash burn, a $4.04 million net current liability deficit and an auditor warning leave its growth strategy dependent on fresh execution and funding. The ASX-listed loyalty technology company is also pursuing acquisitions and a $5 million Marketplacer investment whose benefits have yet to reach reported earnings.

Temas Resources has generated its first revenue from its regenerative chloride leaching technology, but the milestone arrives alongside a wider first-half loss, declining cash and an explicit need for further funding by Q4 2026. The company ended June with C$3.39 million in cash and a C$933,940 estimated flow-through tax liability.

G50 Corp has moved from early-stage exploration towards a two-project drilling campaign, backed by a post-year-end A$26.25 million placement. The company remains loss-making and reliant on exploration success, but says the capital allows uninterrupted work at its Arizona and Nevada projects.

Metal Powder Works has converted its first copper infiltration order into a two-year agreement worth approximately US$600,000, adding contracted demand ahead of its planned capacity expansion. Supply is scheduled to begin in January 2027.

Ark Mines has reported a FY2026 profit after receiving Queensland-backed funding, while its Sandy Mitchell rare earths resource expanded to 379.4 million tonnes after year end. The project now has development approvals and commercial-grade testwork behind it, but no Ore Reserve or mining decision yet.

Athena Resources has expanded its Byro Magnetite Project resource to 76.3 million tonnes and begun drilling at Narryer, the prospect earmarked for potential early development. The progress came with a $1.11 million FY2026 loss, a non-binding joint venture and fresh funding still supporting an exploration-stage business.

Telix has secured FDA Fast Track designation for BiPASS, its Phase 3 program testing 68Ga-PSMA-PET alongside MRI before prostate biopsy. The milestone may support closer FDA engagement and faster review of a planned NDA, but the indication remains investigational and no BiPASS results were disclosed.

Metallium has moved Flash Joule Heating from tiny laboratory tests to multi-reactor campaigns in Texas, backed by feedstock contracts, offtake and A$125 million raised during FY2026. Yet the ASX-listed group remains pre-revenue, lost A$42.8 million and says continued access to funding is a material uncertainty.

Parkway Corporate Limited (ASX:PWN) delivered a sharp revenue increase in FY26 and generated positive operating cash flow, but slipped into a statutory loss and flagged significant uncertainty around its ability to continue as a going concern. Key approvals for its Queensland brine project and a new $2 million mining contract offer commercial progress, while funding remains the central test.

Identitii’s BNDRY platform gained customers and recurring revenue in FY26, but the company ended the year with just $107,483 in cash, negative net assets and a material uncertainty over its ability to continue as a going concern. A subsequent convertible note facility provides a committed $5 million, while access to a further $15 million remains conditional.

American Tungsten & Antimony has paired a sharply higher FY2026 loss with its most consequential strategic step yet: a proposed US mine-to-metal chain anchored by the Del Sol refinery. The acquisition remains unfinished, but the company has produced antimony ingot from Arizona mine material and ended the year with $19.5 million in cash.